Sander J W
University Department of Clinical Neurology, Institute of Neurology, London, England.
Epilepsia. 1993 Nov-Dec;34(6):1007-16. doi: 10.1111/j.1528-1157.1993.tb02126.x.
The traditional view that epilepsy is usually a chronic condition in which the prognosis is consistently poor has been challenged in the last 2 decades. Evidence from population-based studies and from intervention studies in newly diagnosed patients has produced a wealth of information of a much better prognosis. It is now generally accepted that as many as 70-80% of people developing seizures for the first time will eventually achieve terminal remission, whereas the remaining 20-30% will continue to have recurrent seizures despite all treatment. Despite the high recurrence rate after a first epileptic seizure, remission usually occurs early and for most persons, epilepsy is a short-lived condition. The exact role of antiepileptic drugs (AEDs) in this good outcome, however, remains open to debate, because the natural history of the untreated condition is largely unknown. In this article, factors that may influence the prognosis of the epilepsies, including the problems of diagnosis, are reviewed. Special emphasis is given to the issue of spontaneous remission and the question of prognosis of different epileptic syndromes.
过去20年里,癫痫通常是一种预后始终不佳的慢性疾病这一传统观点受到了挑战。基于人群的研究以及针对新诊断患者的干预性研究提供了大量信息,表明癫痫预后要好得多。现在人们普遍认为,首次发生癫痫发作的患者中,多达70%-80%最终会实现彻底缓解,而其余20%-30%的患者尽管接受了所有治疗仍会反复发作。尽管首次癫痫发作后复发率很高,但缓解通常发生得较早,而且对大多数人来说,癫痫是一种短暂的疾病。然而,抗癫痫药物(AEDs)在这一良好预后中的确切作用仍有待争论,因为未治疗情况下的自然病程很大程度上尚不清楚。本文回顾了可能影响癫痫预后的因素,包括诊断问题。特别强调了自发缓解问题以及不同癫痫综合征的预后问题。